Watchlists Portfolios Alerts Sign in Get started

Menu

Immatics N.V. IMTX

Full chart Compare

Set alert

6.36 USD +0.18 (+2.91%)

At closeNov 6, 2026, 4:00 PM EST

6.36 0.00 0.00%

After hours · Nov 6, 4:00 PM ET

6.10 Day range 6.42

6.09 52-week range 12.41

YTD: -39.43%
1 year: -31.09%

News

2 weeks ago benzinga.com Reported Saturday, Immatics Reports IMA203CD8 Cell Therapy 51% ORR, 41% cORR Across Multiple Solid Tumors With Manageable Safety; IMA402 Bispecific Shows 32% cORR In PRAME-High Melanoma, Favorable Safety Profile IMA402 PRAME bispecific continues to demonstrate encouraging anti-tumor activity in multiple indications, alongside a favorable safety profileIMA402 achieved a cORR of 32%, 12.5 months median DOR and…
3 weeks ago benzinga.com This Entegris Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday Analysts initiated coverage on VYLR, IMTX, ENTG, SLGL and SPTX, assigning Neutral, Buy or Overweight ratings and price targets.
3 weeks ago benzinga.com Stifel Initiates Coverage On Immatics with Buy Rating, Announces Price Target of $15 Stifel analyst Laura Prendergast initiates coverage on Immatics (NASDAQ:IMTX) with a Buy rating and announces Price Target of $15.